Signaling through G proteins in platelets: To the integrins and beyond

Thrombosis and Haemostasis

Volumn 78, Issue 1, 1997, Pages 581-589

  Brass, Lawrence F ^a   Manning, David R ^a   Cichowski, Karen ^a   Abrams, Charles S ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL SURFACE RECEPTOR; FIBRINOGEN RECEPTOR; GUANINE NUCLEOTIDE BINDING PROTEIN; INTEGRIN; PLECKSTRIN;

CELL GRANULE; CELL SHAPE; CONFERENCE PAPER; CYTOSKELETON; MOLECULAR WEIGHT; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; THROMBOCYTE; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION; THROMBOCYTE MEMBRANE;

EID: 0030877837     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0038-1657593     Document Type: Conference Paper

References (98)

1. Abrams CS, Wu H, Zhao W, Belmonte E, White D, Brass LF: Pleckstrin inhibits phosphoinositide hydrolysis initiated by G-protein-coupled and growth factor receptors. A role for pleckstrin's PH domains. J Biol Chem 1995; 270:14485-14492.
2. Abrams CS, Zhang J, Downes CP, Tang XW, Zhao W, Rittenhouse SE: Phosphopleckstrin inhibits Gβγ-activable platelet phosphatidylinositol-4,5-bisphosphate 3-kinase. J Biol Chem 1996; 271:25192-25197.
3. Abrams CS, Zhao W, Belmonte E, Brass LF: Protein kinase C regulates pleckstrin by phosphorylation of sites adjacent to the N-terminal pleckstrin homology domain. J Biol Chem 1995; 270:23317-23321.
4. βgamma. Biochim Biophys Acta Mol Cell Res 1996; 1314:233-238.
5. α16, a G protein a subunit specifically expressed in hematopoietic cells. Proc Natl Acad Sci USA 1991; 88:5587-5591.
6. Barr AJ, Brass LF, Manning DR: Reconstitution of receptors and GTP-binding regulatory proteins (G proteins) in Sf9 cells: a direct evaluation of selectivity in receptor-G protein coupling. J Biol Chem 1997; 272:2223-2229.
7. Bennett BD, Cowley S, Jiang S, et al: Identification and characterization of a novel tyrosine kinase from megakaryocytes. J Biol Chem 1994; 269:1068-1074.
8. Bennett JS, Vilaire G, Burch JW: A role for prostaglandins and thromboxanes in the exposure of platelet fibrinogen receptors. J Clin Invest 1981; 68:981-987.
9. Berridge MJ: Inositol trisphosphate and calcium signalling. Nature 1993; 361:315-325.
10. Bichet DG, Arthus M-F, Barjon JN, Lonergan M, Kortas C: Human platelet fraction arginine-vasopressin: potential physiological role. J Clin Invest 1987; 79:881-887.
11. Birnbaumer L: Receptor-to-effector signaling through G proteins: Roles for bg dimers as well as a subunits. Cell 1992; 71:1069-1072.
12. Brass LF, Hoxie JA, Manning DR: Signaling through G proteins and G protein-coupled receptors during platelet activation. Thromb Haemost 1993; 70:217-223.
13. i. J Biol Chem 1986; 261:16838-16847.
14. Brass LF, Manning DR, Williams A, Woolkalis MJ, Poncz M: Receptor and G protein-mediated responses to thrombin in HEL cells. J Biol Chem 1991; 266:958-965.
15. Brass LF, Molino M: Protease-activated G protein-coupled receptors on human platelets and endothelial cells. Thromb Haemost 1997; in press:
16. Brass LF, Shaller CC, Belmonte EJ: Inositol 1,4,5-triphosphate-induced granule secretion in platelets. Evidence that the activation of phospholipase C mediated by platelet thromboxane receptors involves a guanine nucleotide binding protein-dependent mechanism distinct from that of thrombin. J Clin Invest 1987; 79:1269-1275.
17. Brass LF, Vassallo RR, Jr., Belmonte E, Ahuja M, Cichowski K, Hoxie JA: Structure and function of the human platelet thrombin receptor: studies using monoclonal antibodies against a defined epitope within the receptor N-terminus. J Biol Chem 1992; 267:13795-13798.
18. Brass LF, Woolkalis MJ, Manning DR: Interactions in platelets between G proteins and the agonists that stimulate phospholipase C and inhibit adenylyl cyclase. J Biol Chem 1988; 263:5348-5355.
19. Börsch-Haubold AG, Kramer RM, Watson SP: Inhibition of mitogen-activated protein kinase kinase does not impair primary activation of human platelets. Biochem J 1996; 318:207-212.
20. Carey F, Menashi S, Crawford N: Localization of cyclo-oxygenase and thromboxane synthetase in human platelet intracellular membranes. Biochem J 1982; 204:847-851.
21. Carlson K, Brass LF, Manning DR: Thrombin and phorbol esters cause the selective phosphorylation of a G protein other than a in human platelets. J Biol Chem 1989; 264:13298-13305.
22. z, a guanine nucleotide-binding protein with unique biochemical properties. J Biol Chem 1990; 265:2383-2390.
23. Chao W, Olson MS: Platelet-activating factor: Receptors and signal transduction. Biochem J 1993; 292:617-629.
24. vav, in platelets. J Biol Chem 1996; 271:7544-7550.
25. 3. J Biol Chem 1994; 269:28859-28864.
26. Cockcroft S, Thomas GMH: Inositol-lipid-specific phospholipase C isoenzymes and their differential regulation by receptors. Biochem J 1992; 288:1-14.
27. Connolly AJ, Ishihara H, Kahn ML, Farese RV, Jr., Coughlin SR: Role of the thrombin receptor In development and evidence for a second receptor. Nature 1996; 381:516-519.
28. Crespo P, Bustelo XR, Aaronson DS, et al: Rac-1 dependent stimulation of the JNK/SAPK signaling pathway by Vav. Oncogene 1996; 13:455-460.
29. Crespo P, Schuebel KE, Ostrom AA, Gutkind JS, Bustelo XR: Phosphotyrosine-dependent activation of Rac-1 GDP/GTP exchange by the vav proto-oncogene product. Nature 1997; 385:169-172.
30. 3 formation in human platelets. FEBS Lett 1986; 206:299-303.
31. Deckert M, Tartare-Deckert S, Couture C, Mustelin T, Altman A: Functional and physical interactions of Syk family kinases with the Vav proto-oncogene product. Immunity 1996; 5:591-604.
32. Dikic I, Tokiwa G, Lev S, Courtneidge SA, Schlessinger J: A role for Pyk2 and Src in linking G-protein-coupled receptors with MAP kinase activation. Nature 1996; 383:547-550.
33. Fields TA, Casey PJ: . J Biol Chem 1995; 270:23119-23125.
34. Fisher GJ, Bakshian S, Baldassare JJ: Activation of human platelets by ADP causes a rapid rise in cytosolic free calcium without hydrolysis of phosphatidylinositol-4,5-bisphosphate. Biochem Biophys Res Commun 1985; 129:958-964.
35. 2 as an amplifying signal for other agonists. Am J Cardiol 1991; 68:11B-15B.
36. Frojmovic MM, Wong T, Searcy GP: Platelets from bleeding simmental cattle have a long delay in both ADP-activated expression of GpIIb-IIIa receptors and fibrinogen-dependent platelet aggregation. Thromb Haemost 1996; 76:1047-1052.
37. 2 receptors: Distinct subtypes mediate vascular smooth muscle contraction and platelet aggregation. J Pharmacol Exp Ther 1991; 258:74-81.
38. zα as a pertussis toxin-insensitive G protein in human platelets and megakaryocytes. Blood 1991; 78:1247-1253.
39. Gerrard JM, Carroll RC: Stimulation of protein phosphorylation by arachidonic acid and endoperoxide analog. Prostaglandins 1981; 22:81-94.
40. 2+ in quin 2-loaded human platelets mainly by influx across the plasma membrane. Thromb Haemost 1983; 50:76.
41. 2 receptor antagonists. Biochem Pharmacol 1988; 37:3923-3929.
42. Harlan JE, Hajduk PJ, Yoon HS, Fesik SW: Pleckstrin homology domains bind to phophatidylinositol-4,5-bisphosphate. Nature 1994; 371:168-170.
43. Haslam RJ, Kolde BJ, Hemmings BA: Pleckstrin domain homology. Nature 1993; 363:309-310.
44. Haslam RJ, Lynham JA, Fox JEB: Effects of collagen, ionophore A23187 and prostaglandin El on the phosphorylation of specific proteins in blood platelets. Biochem J 1979; 178:397-406.
45. Hawes BE, Luttrell LM, Van Biesen T, Lefkowitz RJ: Phosphatidylinositol 3-kinase is an early intermediate in the Gβγ-mediated mitogen-activated protein kinase signaling pathway. J Biol Chem 1996; 271:12133-12136.
46. Hellevuo K, Yoshimura M, Kao M, Hoffman PL, Cooper DM, Tabakoff B: A novel adenylyl cyclase sequence cloned from the human erythroleukemia cell line. Biochem Biophys Res Commun 1993; 192:311-318.
47. 2 receptor. Nature 1991; 349:617-620.
48. Honda Z, Nakamura M, Miki I, et al: Cloning by functional expression of platelet-activating factor receptor from guinea-pig lung. Nature 1991; 349:342-346.
49. 2 antagonist 13-azaprostanoic acid to human platelet membranes. Biochim Biophys Acta 1983; 728:171-178.
50. Imaoka T, Lynham JA, Haslam RJ: Purification and characterization of the 47,000-dalton protein phosphorylated during degranulation of human platelets. J Biol Chem 1983; 258:11404-11414.
51. Inaba K, Umeda Y, Yamane Y, Urakami M, Inada M: Characterization of human platelet vasopressin receptor and the relation between vasopressin-induced platelet aggregation and vasopressin binding to platelets. Clin Endocrinol (Oxf) 1988; 29:377-386.
52. Kaywin P, McDonough M, Insel PA, Shattil SJ: Platelet function in essential thrombocythemia: decreased epinephrine responsivenesss associated with a deficiency of platelet alpha-adrenergic receptors. N Engl J Med 1978; 299:505-509.
53. 2-adrenergic receptor. Science 1987; 238:650-656.
54. 2+-dependent human platelet phospholipase A2. Biochim Biophys Acta 1986; 878:394-403.
55. 2. J Biol Chem 1996; 271:27723-27729.
56. Laposata M, Krueger CM, Saffitz JE: Selective uptake of [3H]arachidonic acid into the dense tubular system of human platelets. Blood 1987; 70:832-837.
57. +2-induced regulation of ion channel and MAP kinase functions. Nature 1995; 376:739-744.
58. Lin L-L, Wartmann M, Lin AY, Knopf JL, Seth A, Davis RJ: cPLA2 is phosphorylated and activated by MAP kinase. Cell 1993; 72:269-278.
59. Lopez-Ilasaca M, Crespo P, Pellici PG, Gutkind JS, Wetzker R: Linkage of G protein-coupled receptors to the MAPK signaling pathway through PI 3-kinase gamma. Science 1997; 275:394-397.
60. Lounsbury KM, Brass LF, Manning DR: Phosphorylation of Gza in human platelets: proximity to the amino-terminus of the subunit. J Cell Biol 1990; 111:334a.
61. z in human platelets: selectivity and site of modification. J Biol Chem 1991; 266:22051-22056.
62. zα by site-directed mutagenesis: sites and specificity of protein kinase C-dependent phosphorylation. J Biol Chem 1993; 268:3494-3498.
63. βgamma subunit-mediated activation of mitogen-activated protein kinases. J Biol Chem 1996; 271:19443-19450.
64. Ma A, Brass LF, Abrams CS: Pleckstrin-mediated induction of villous projections requires phosphorylation and an intact N-terminal PH domain. J Cell Biol 1997; in press:
65. Mayer BJ, Ren R, Clark KL, Baltimore DL: A putative modular domain present in diverse signaling proteins. Cell 1993; 73:629-630.
66. Mege D, Di Bartolo V, Germain V, Tuosto L, Michel F, Acuto O: Mutation of tyrosines 492/493 in kinase domain of ZAP-70 affects multiple T-cell receptor signaling pathways. J Biol Chem 1996; 271:32644-32652.
67. Mills DCB: ADP receptors on platelets. Thromb Haemost 1996; 76:835-856.
68. Molino M, Bainton DF, Hoxie JA, Coughlin SR, Brass LF: Thrombin receptors on human platelets: initial localization and subsequent redistribution during platelet activation. J Biol Chem 1997; 272:6011-6017.
69. Morii N, Teru-uchi T, Tominaga T, et al: A rho gene product in human blood platelets. II. Effects of the ADP-ribosylation by botulinum C3 ADP-ribosyltransferase on platelet aggregation. J Biol Chem 1992; 267:20921-20926.
70. 3H]rauwolscine. Biochem Pharmacol 1982; 31:2591-2597.
71. Musacchio A, Gibson T, Rice P, Thompson J, Saraste M: The PH domain: a common piece in the structural patchwork of signalling proteins. TIBS 1993; 18:343-348.
72. Nemoto Y, Namba T, Teru-uchi T, Ushikubi F, Morii N, Narumiya S: A rho gene product in human blood platelets. I. Identification of the platelet substrate for botulinum C3 ADP-ribosyltransferase as rhoA protein. J Biol Chem 1992; 267:20916-20920.
73. α13 are phosphorylated during platelet activation. J Biol Chem 1996; 271:26044-26048.
74. 2 and thrombin receptors in human platelets. Proc Natl Acad Sci USA 1994; 91:504-508.
75. Papkoff J, Chen R-H, Blenis J, Forsman J: p42 Mitogen-activated protein kinase and p90 ribosomal S6 kinase are selectively phosphorylated and activated during thrombin-induced platelet activation and aggregation. Mol Cell Biol 1994; 14:463-472.
76. Peerschke EI: Induction of human platelet fibrinogen receptors by epinephrine in the absence of released ADP. Blood 1982; 60:71-77.
77. Ponting CP, Bork P: Pleckstrin's repeat performance: A novel domain in G-protein signaling? Trends Biochem Sci 1996; 21:245-246.
78. 2 receptor in human platelet membranes. J Biol Chem 1986; 261:3025-3029.
79. q family. J Biol Chem 1991; 266:9309-9313.
80. Sidorenko SP, Law C-L, Chandran KA, Clark EA: Human spleen tyrosine kinase p72Syk associates with the Src-family kinase p53/56Lyn and a 120-kDa phosphoprotein. Proc Natl Acad Sci USA 1995; 92:359-363.
81. Siess W, Siegel FL, Lapetina EG: Arachidonic acid stimulates the formation of 1,2-diacylglycerol and phosphatidic acid in human platelets. Degree of phospholipase C activation correlates with protein phosphorylation, platelet shape change, serotonin release, and aggregation. J Biol Chem 1983; 258:11236-11242.
82. Siess W, Stifel M, Binder H, Weber P: Activation of V1-receptors by vasopressin stimulates inositol phospholipid hydrolysis and arachidonate metabolism in human platelets. Biochem J 1986; 233:83-91.
83. Siess W, Weber PC, Lapetina EG: Activation of phospholipase C is dissociated from arachidonate metabolism during platelet shape change induced by thrombin or platelet-activating factor. Epinephrine does not induce phospholipase C activation or platelet shape change. J Biol Chem 1984; 259:8286-8292.
84. Smith SK, Limbird LE: Evidence that human platelet α-adrenergic receptors coupled to inhibition of adenylate cyclase are not associated with the subunit of adenylate cyclase ADP-ribosylated by cholera toxin. J Biol Chem 1982; 257:10471-10478.
85. α13 subunits define a fourth class of G protein a subunits. Proc Natl Acad Sci USA 1991; 88:5582-5586.
86. ia. Science 1993; 261:218-221.
87. Thomason PA, James SR, Casey PJ, Downes CP: A G-protein βgamma-subunit-responsive phosphoinositide 3-kinase activity in human platelet cytosol. J Biol Chem 1994; 269:16525-16528.
88. Tyers M, Rachubinski RA, Stewart MT, et al: Molecular cloning and expression of the major protein kinase C substrate of platelets. Nature 1988; 333:470-473.
89. Van Willigen G, Donath J, Lapetina EG, Akkerman JWN: Identification of a-subunits of trimeric GTP-binding proteins in human platelets by RT-PCR. Biochem Biophys Res Commun 1995; 214:254-262.
90. Vittet D, Cantau B, Mathieu M-N, Chevillard C: Properties of vasopressin-activated human platelet high affinity GTPase. Biochem Biophys Res Commun 1988; 154:213-218.x
91. Vu T-KH, Hung DT, Wheaton VI, Coughlin SR: Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation. Cell 1991; 64:1057-1068.
92. Vu T-KH, Wheaton VI, Hung DT, Charo I, Coughlin SR: Domains specifying thrombin-receptor interaction. Nature 1991; 353:674-677.
93. Williams A, Woolkalis MJ, Poncz M, Manning DR, Gewirtz A, Brass LF: Identification of the pertussis toxin-sensitive G proteins in platelets, megakaryocytes and HEL cells. Blood 1990; 76:721-730.
94. Wong YH, Conklin BR, Bourne HR: Gz-mediated hormonal inhibition of cyclic AMP accumulation. Science 1992; 255:339-342.
95. Yoshimoto T, Yamamoto S, Okuma M, Hayaishi O: Solubilization and resolution of thromboxane synthesizing system from microsomes of bovine blood platelets. J Biol Chem 1977; 252:5871-5544.
96. Zhang J, Benovic JL, Sugai M, Wetzker R, Gout I, Rittenhouse SE: Sequestration of a G-protein βgamma subunit or ADP-ribosylation of Rho can inhibit thrombin-induced activation of platelet phosphoinositide 3-kinases. J Biol Chem 1995; 270:6589-6594.
97. Zhang J, King WG, Dillon S, Hall A, Feig L, Rittenhouse SE: Activation of platelet phosphatidylinositide 3-kinase requires the small GTP-binding protein Rho. J Biol Chem 1993; 268:22251-22254.
98. 3 integrin. J Biol Chem 1996; 271:6265-6272.